See more : Phathom Pharmaceuticals, Inc. (PHAT) Income Statement Analysis – Financial Results
Complete financial analysis of W-Scope Chungju Plant Co., Ltd. (393890.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of W-Scope Chungju Plant Co., Ltd., a leading company in the Electrical Equipment & Parts industry within the Industrials sector.
- Sichuan Dowell Science and Technology Inc. (300535.SZ) Income Statement Analysis – Financial Results
- C-Com Satellite Systems Inc. (CMI.V) Income Statement Analysis – Financial Results
- Fuel Tech, Inc. (FTEK) Income Statement Analysis – Financial Results
- Zenergy International, Inc. (ZENG) Income Statement Analysis – Financial Results
- Bloom Industries Limited (BLOIN.BO) Income Statement Analysis – Financial Results
W-Scope Chungju Plant Co., Ltd. (393890.KQ)
About W-Scope Chungju Plant Co., Ltd.
W-Scope Chungju Plant Co., Ltd. provides battery parts and materials for automobiles and energy storage. The company was founded in 2016 and is based in Chungju, South Korea.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 304.99B | 257.45B | 185.50B | 111.88B | 34.81B |
Cost of Revenue | 246.45B | 184.50B | 131.92B | 88.94B | 31.34B |
Gross Profit | 58.54B | 72.95B | 53.58B | 22.93B | 3.47B |
Gross Profit Ratio | 19.19% | 28.33% | 28.89% | 20.50% | 9.96% |
Research & Development | 2.45M | 5.40B | 4.01B | 8.19B | 6.14B |
General & Administrative | 1.09B | 666.98M | 284.24M | 133.00M | 0.00 |
Selling & Marketing | 4.42B | 4.84B | 6.10B | 3.36B | 0.00 |
SG&A | 5.51B | 9.36B | 8.70B | 4.91B | 2.36B |
Other Expenses | 6.81B | -158.98M | -418.87M | -65.18M | -25.44M |
Operating Expenses | 12.33B | 14.92B | 13.12B | 13.17B | 8.52B |
Cost & Expenses | 258.60B | 199.42B | 145.04B | 102.11B | 39.86B |
Interest Income | 4.65B | 1.98B | 424.24M | 790.37M | 57.34M |
Interest Expense | 1.77B | 672.12M | 9.16B | 15.75B | 1.40B |
Depreciation & Amortization | 50.48B | 44.03B | 32.05B | 26.74B | 11.07B |
EBITDA | 106.31B | 106.45B | 30.32B | -1.78B | 5.95B |
EBITDA Ratio | 34.86% | 39.64% | 39.09% | 32.63% | 17.27% |
Operating Income | 46.39B | 58.03B | 40.46B | 9.76B | -5.06B |
Operating Income Ratio | 15.21% | 22.54% | 21.81% | 8.72% | -14.52% |
Total Other Income/Expenses | 8.21B | 3.72B | -51.34B | -54.04B | -1.46B |
Income Before Tax | 54.60B | 61.75B | -10.89B | -44.28B | -6.51B |
Income Before Tax Ratio | 17.90% | 23.98% | -5.87% | -39.58% | -18.71% |
Income Tax Expense | 981.16M | 6.49B | -922.59M | -13.10B | 3.00 |
Net Income | 53.62B | 55.26B | -9.96B | -31.18B | -6.51B |
Net Income Ratio | 17.58% | 21.46% | -5.37% | -27.87% | -18.71% |
EPS | 1.59K | 1.64K | -295.70 | -925.27 | -193.31 |
EPS Diluted | 1.59K | 1.64K | -295.70 | -925.27 | -193.31 |
Weighted Avg Shares Out | 33.70M | 33.70M | 33.70M | 33.70M | 33.70M |
Weighted Avg Shares Out (Dil) | 33.70M | 33.70M | 33.70M | 33.70M | 33.70M |
Source: https://incomestatements.info
Category: Stock Reports